INSUBCONTINENT EXCLUSIVE:
taking the total deal value to Rs 118.02 crore
389, swinging to an intra day high of Rs 393.15 and an intra day low of Rs 372.50, in the trading session so far
According to block deal data on BSE, on Monday, May 17, Serum Institute of India (SII) CEO Adar Poonawalla offloaded his entire stake in
Panacea Biotech amounting to 5.15 per cent shareholding of the firm for Rs 118 crore, through an open market transaction.According to the
shareholding data for March 2021 quarter, both Adar Poonawalla and Serum Institute of India were the public shareholders in the firm and
held 5.15 per cent and 4.98 per cent stake in Panacea Biotech, respectively.On the NSE, Panacea Biotech opened at Rs 390, witnessing an
intra day high of Rs 392, and an intra day low of Rs 371, in the session so far
It was last trading 3.12 per cent lower at Rs 373.Shares of Panacea Biotech were last trading 3.35 per cent lower at Rs 373 on the BSE
Pancea Biotech is a global generic and pharmaceutical and vaccine maker registered in the country.
